氟馬西尼市場:用量，各用途，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

預計增加氟馬西尼治療昏迷的研發將推動全球氟馬西尼市場的增長。

本調查的主要特徵

• 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球氟馬西尼市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
• 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
• 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
• 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球氟馬西尼市場的主要參與者之企業簡介。
• 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球氟馬西尼市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以透過全球氟馬西尼市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

• 調查目的
• 前提條件
• 簡稱的說明

第2章 市場概要

• 報告內容
  • 市場定義和範圍
• 摘要整理
  • 市場明細:劑量
  • 市場明細:各應用領域
  • 市場明細，各流通管道
  • 市場明細，各地區
• 連貫機遇地圖(COM)

第3章 市場動態，法規，趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 法規方案
• PEST分析
• 最近的產品上市/核准
• 流行病學
• M&A(合併·收購)

第4章 氟馬西尼的全球市場:冠狀病毒(COVID-19)疫情的影響

• 供應鏈的影響
• 研究開發的影響
• 政府的配合措施

第5章 氟馬西尼的全球市場:各劑量，2017年～2030年

• 5毫升
• 10毫升

第6章 氟馬西尼的全球市場:各用途，2017年～2030年

• 鎮靜劑
• 消除困倦
• 其他(肝性腦病變，肝硬化)

第7章 氟馬西尼的全球市場:各流通管道，2017年～2030年

• 醫院內藥局
• 零售藥局
• 線上藥局

第8章 氟馬西尼的全球市場:各地區，2017年～2030年

• 北美
• 美國
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美地區
• 歐洲
• 德國
• 英國
• 法國
• 義大利
• 西班牙
• 俄羅斯
• 其他的歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• ASEAN
• 其他亞太地區
• 中東地區
• GCC
• 以色列
• 其他的中東地區
• 非洲
• 南非
• 中非
• 北非

第9章 競爭情形

• 企業簡介
  • Hoffmann La Roche
• 藥物組合
  • Akorn-Strides, LLC
• 醫藥品組合
  • Sandoz Canada Incorporated
• 醫藥品組合
  • Fresenius Kabi USA, LLC
• 醫藥品組合
  • Mylan Pharmaceuticals
• 醫藥品組合
  • Genentech, Inc.
• 藥物組合
  • General Injectables & Vaccines Inc
• 藥物組合
  • Sina Health Inc.
• 藥物組合
  • West Ward Pharmaceutical
• 藥物組合
  • HF Acquisition Co. LLC, DBA HealthFirst
• 藥物組合
  • Hikma Farmaceutica
• 藥物組合
  • Pfizer Laboratories Div Pfizer Inc.
• 藥物組合
  • Physicians Total Care, Inc.
• 藥物組合
  • Bedford Pharmaceuticals
• 藥物組合

第10章 章節

• 參考文獻
• 調查手法

Flumazenil is a benzodiazepine inhibitor Flumazenil are used as reversal drug for postsurgical sedation from benzodiazepine anesthetics. Flumazenil injection is recommended for a complete or partial reversal of the sedative effects of benzodiazepines in conscious sedation and general anesthesia in adult and pediatric populations.

Flumazenil is also designated for the management and treatment of benzodiazepine overdose in adults. It is used in reversing coma due to benzodiazepine overdose. Flumazenil is more effective in reversing coma in benzodiazepine intoxication than patients with multiple drug overdoses.

Market Dynamics

Increasing research and development for the treatment of coma using flumazenil is expected to propel growth of the global flumazenil market. For instance, according to research data published on May 9, 2021, in Journal of Medical Case Reports, researchers have reported that flumazenil has showed positive result in complete neurocognitive recovery of patient with a Glasgow Coma Score of 15. 0.25 mg of flumazenil was intravenously administered to the patient who was unresponsive with Glass Coma Score of 3. After the patient was directed with flumazenil, the patient completely recovered by neurocognitive.

Increasing cases of people facing drowsiness problem is expected to drive growth of the global flumazenil market, over the forecast period. For instance, according to data published by European Transport Workers' Federation, in 2019 a survey done in city of London, reported that among 1353 bus drivers 37% of the drivers had to fight with drowsiness in order to stay awake. Flumazenil is used for the treatment of patients suffering from drowsiness. Flumazenil injections given through vein are more effective to treat people facing drowsiness.

Key features of the study:

• This report provides an in-depth analysis of the global flumazenil market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global flumazenil market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Hoffmann La Roche, Akorn-Strides, LLC, Sandoz Canada Incorporated, Fresenius Kabi USA, LLC, Mylan Pharmaceuticals, Genentech, Inc., General Injectables & Vaccines Inc, Sina Health Inc, West Ward Pharmaceutical, HF Acquisition Co. LLC, DBA HealthFirst, Hikma Farmaceutica, Pfizer Laboratories Div Pfizer Inc., Physicians Total Care, Inc., and Bedford Pharmaceuticals
• Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global flumazenil market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global flumazenil market.

Detailed Segmentation:

• Global Flumazenil Market, By Dose:
  • 5 ml
  • 10 ml
• Global Flumazenil Market, By Application:
  • Anti - Sedation
  • Reversing Drowsiness
  • Others (Hepatic Encephalopathy, Cirrhosis)
• Global Flumazenil Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Flumazenil Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Hoffmann La Roche *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Akorn-Strides, LLC
  • Sandoz Canada Incorporated
  • Fresenius Kabi USA, LLC
  • Mylan Pharmaceuticals
  • Genentech, Inc.
  • General Injectables & Vaccines Inc
  • Sina Health Inc
  • West Ward Pharmaceutical
  • HF Acquisition Co. LLC, DBA HealthFirst
  • Hikma Farmaceutica
  • Pfizer Laboratories Div Pfizer Inc.
  • Physicians Total Care, Inc.
  • Bedford Pharmaceuticals

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Dose
  • Market Snippet, By Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Regulatory Scenario
• PEST Analysis
• Recent Product Launch/Approval
• Epidemiology
• Mergers and Acquisitions

4. Global Flumazenil Market - Impact of Coronavirus (Covid-19) Pandemic

• Impact on Supply Chain
• Impact on Research and Development
• Government Initiatives

5. Global Flumazenil Market, By Dose, 2017-2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• 5 ml
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• 10 ml
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Flumazenil Market, By Application, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Anti - Sedation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Reversing Drowsiness
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Others (Hepatic Encephalopathy, Cirrhosis)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Flumazenil Market, By Distribution Channel, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Flumazenil Market, By Region, 2017 - 2030 (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
  • Regional Trends
• North America
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• U.S.
• Canada
• Latin America
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Market Size and Forecast, By Dose, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2030 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
• South Africa
• Central Africa
• North Africa

9. Competitive Landscape

• Company Profiles
  • Hoffmann La Roche
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Akorn-Strides, LLC
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Sandoz Canada Incorporated
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Fresenius Kabi USA, LLC
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Mylan Pharmaceuticals
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Genentech, Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • General Injectables & Vaccines Inc
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Sina Health Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • West Ward Pharmaceutical
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • HF Acquisition Co. LLC, DBA HealthFirst
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Hikma Farmaceutica
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Pfizer Laboratories Div Pfizer Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Physicians Total Care, Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
  • Bedford Pharmaceuticals
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Analyst Views

10. Section

• References
• Research Methodology
• About us and Sales Contact